Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Etentamig by AbbVie for Primary Systemic Amyloidosis: Likelihood of Approval
Etentamig is under clinical development by AbbVie and currently in Phase II for Primary Systemic Amyloidosis. According to GlobalData, Phase...